Monoclonal antibodies for the Treatment and Prevention of Enterovirus EV-D68 Infection
$1,499,394N01FY2021AINIH
Idbiologics, Llc, Nashville TN
Investigators
Abstract
To develop monoclonal antibodies (mAb) as a treatment against EV-D68 infection in children.
View original record on NIH RePORTER →